The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study
Božek, T., Bilić Ćurčić, I., Cigrovski Berković, M., Gradišer, M., Tićinović Kurir, T., Klobučar Majanović, S. & Marušić, S. (2018). The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study. Diabetology and Metabolic Syndrome, 10.. doi: 10.1186/s13098-018-0321-x
Božek, Tomislav, et al. "The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study." Diabetology and Metabolic Syndrome, vol. 10, 2018. https://doi.org/10.1186/s13098-018-0321-x
Božek, Tomislav, Ines Bilić Ćurčić, Maja Cigrovski Berković, Marina Gradišer, Tina Tićinović Kurir, Sanja Klobučar Majanović and Srećko Marušić. "The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study." Diabetology and Metabolic Syndrome 10 (2018). https://doi.org/10.1186/s13098-018-0321-x
Božek, T., et al. (2018) 'The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study', Diabetology and Metabolic Syndrome, 10. doi: 10.1186/s13098-018-0321-x
Božek T, Bilić Ćurčić I, Cigrovski Berković M, Gradišer M, Tićinović Kurir T, Klobučar Majanović S, and sur.. The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study. Diabetology and Metabolic Syndrome [Internet]. 2018 March 13 [cited 2024 December 03];10. doi: 10.1186/s13098-018-0321-x
T. Božek, et al., "The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study", Diabetology and Metabolic Syndrome, vol. 10, March 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:714639. [Accessed: 03 December 2024]